disease_target_phase,primary_use_case,assay_aim,assay_target,target_analyte,drug_resistance_target,other_drug_resistance_target,validated_sample_types,other_validated_sample_type,submission_id,submission_title,manufacturer,country,region,stage_of_development,regulatory_status,other_regulatory_status,target_pathogen,planned_market_entry,type_of_technology,technology_principle,test_format,instrument_requirement,lab_vs_poc,readout_technology,resistance_marker,other_test_format,level_of_automation,self_testing_self_collection,time_to_results_excl_prep,test_to_be_listed_on_finds_web_page,data_to_be_published_on_finds_web_page,target_patient_group,type_data_source,study_type,performance_submission_title,sensitivity,sensitivity_ci_low,sensitivity_ci_up,specificity,specificity_ci_low,specificity_ci_up,total_number_samples,sample_type,number_positive_samples,number_negative_samples,city,permalink,country_tmp,city2,lat,lng,who_technology_class,who_pipe
Active,Diagnostic/confirmatory test,Tuberculosis,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000007lbEm,Determine TB-LAM Ag,Abbott Rapid Diagnostics,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,25,Yes,Yes,Active TB,Other,Independent,TB detection from urine (HIV+ patients),42,31,55,91,85,95,3449,Urine,1277,2172,Groß-Rohrheim,https://globalpointofcare.abbott/en/index.html,Germany,"Groß-Rohrheim, Germany",49.71524811,8.47291756,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000007lbEm,Determine TB-LAM Ag,Abbott Rapid Diagnostics,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,25,Yes,Yes,Active TB,Other,Independent,TB detection from urine (overall symptomatic HIV+ patients),42,31,55,91,85,95,3449,Urine,1277,2172,Groß-Rohrheim,https://globalpointofcare.abbott/en/index.html,Germany,"Groß-Rohrheim, Germany",49.71524811,8.47291756,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000007lbEm,Determine TB-LAM Ag,Abbott Rapid Diagnostics,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,25,Yes,Yes,Active TB,Other,Independent,TB detection from urine (overall unselected HIV+ patients),35,22,50,95,89,98,3365,Urine,432,2933,Groß-Rohrheim,https://globalpointofcare.abbott/en/index.html,Germany,"Groß-Rohrheim, Germany",49.71524811,8.47291756,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000007lbEm,Determine TB-LAM Ag,Abbott Rapid Diagnostics,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,25,Yes,Yes,Active TB,Other,Independent,TB detection from urine (symptomatic HIV+ inpatient),52,40,64,87,78,93,2253,Urine,868,1385,Groß-Rohrheim,https://globalpointofcare.abbott/en/index.html,Germany,"Groß-Rohrheim, Germany",49.71524811,8.47291756,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000007lbEm,Determine TB-LAM Ag,Abbott Rapid Diagnostics,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,25,Yes,Yes,Active TB,Other,Independent,TB detection from urine (symptomatic HIV+ outpatient),29,17,47,96,91,99,1196,Urine,409,787,Groß-Rohrheim,https://globalpointofcare.abbott/en/index.html,Germany,"Groß-Rohrheim, Germany",49.71524811,8.47291756,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000007lbEm,Determine TB-LAM Ag,Abbott Rapid Diagnostics,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,25,Yes,Yes,Active TB,Other,Independent,TB detection from urine (unselected HIV+ inpatient),62,41,83,84,48,96,537,Urine,159,378,Groß-Rohrheim,https://globalpointofcare.abbott/en/index.html,Germany,"Groß-Rohrheim, Germany",49.71524811,8.47291756,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis,Antigen,Lipoarabinomannan (LAM),Not applicable,NA,Urine,NA,a2r69000007lbEm,Determine TB-LAM Ag,Abbott Rapid Diagnostics,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Immunoassay,Lateral Flow Assay,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,25,Yes,Yes,Active TB,Other,Independent,TB detection from urine (unselected HIV+ outpatient),31,18,47,95,87,99,2828,Urine,273,2555,Groß-Rohrheim,https://globalpointofcare.abbott/en/index.html,Germany,"Groß-Rohrheim, Germany",49.71524811,8.47291756,Low complexity,WHO
Latent,Triage/Screening,Tuberculosis,Antigen,Private,Not applicable,NA,Whole Blood,NA,a2r69000007lb91,IP-10 IGRA LF,R-Biopharm AG,Germany,European Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Private,Rapid diagnostic test (strip or cassette),No instrumentation is required,near Point of Care,Colorimetric,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Darmstadt,https://r-biopharm.com,Germany,"Darmstadt, Germany",49.87237167,8.6509819,Low complexity,Pipe
Latent,Triage/Screening,Tuberculosis,Antigen,Private,Not applicable,NA,Whole Blood,heprin,a2r69000007lbFH,IP-10 IGRA ELISA,R-Biopharm AG,Germany,European Region,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Private,Chemiluminescent Immunoassay (CLIA),Standard lab instrumentation is required,Lab-based,Colorimetric,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Darmstadt,https://r-biopharm.com,Germany,"Darmstadt, Germany",49.87237167,8.6509819,Not applicable,Pipe
Latent,Triage/Screening,Tuberculosis,Antigen,Private,Not applicable,NA,Plasma,NA,a2r69000007lbFL,STANDARD E TB-Feron ELISA,"SD Biosensor, Inc.","Korea, Republic of",Western Pacific Region,Regulatory Achieved,CE-IVDD; Korea MFDS,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Private,Chemiluminescent Immunoassay (CLIA),Standard lab instrumentation is required,Lab-based,Colorimetric,Private,NA,Manual,Intended for professional use only,100,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Suwon-si,https://sdbiosensor.com,South Korea,"Suwon-si, Korea, Republic of",37.25973511,127.00894928,Not applicable,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Private,Isoniazid; Pyrazinamide; Rifampicin,NA,Unknown,NA,a2r69000007lbEo,INFINITIMTB Assay,Autogenomics,United States,Region of the Americas,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,Lab-based,Fluorescence,Private,microarray chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Carlsbad,https://autogenomics.com/?q=node/42,United States,"Carlsbad, United States",33.16603851,-117.33792877,Not applicable,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Private,Amikacin; Fluoroquinolone; Isoniazid; Kanamycin; Rifampicin,NA,Sputum,NA,a2r69000007lbF6,IRON qPCR RFIA kit (preXDR-TB),Bioneer Corporation,"Korea, Republic of",Western Pacific Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Fully automated (including sample preparation),Intended for professional use only,60,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Daejeon,https://bioneer.com,South Korea,"Daejeon, Korea, Republic of",36.34912872,127.38493346999999,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB rpoB gene,Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb94,Xpert MTB/RIF,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; US FDA 510k; WHO recommended; Other,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,RIF detection (against AFB smear positive subjects ),99.7,98.4,99.9,98.5,91.9,99.7,417,Sputum,351,66,Sunnyvale,https://cepheid.com,United States,"Sunnyvale, United States",37.3736763,-122.03657532,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB rpoB gene,Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb94,Xpert MTB/RIF,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; US FDA 510k; WHO recommended; Other,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,RIF detection (against AFB smear negative subjects ),76.1,67.6,82.9,98.8,97.5,99.4,679,Sputum,117,562,Sunnyvale,https://cepheid.com,United States,"Sunnyvale, United States",37.3736763,-122.03657532,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB rpoB gene,Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb94,Xpert MTB/RIF,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; US FDA 510k; WHO recommended; Other,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,Yes,Active TB,Other,Independent,TB detection from sputum,85,82,88,98,97,98,37237,Sputum,NA,NA,Sunnyvale,https://cepheid.com,United States,"Sunnyvale, United States",37.3736763,-122.03657532,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB rpoB gene,Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb94,Xpert MTB/RIF,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; US FDA 510k; WHO recommended; Other,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,Yes,Active TB,Other,Independent,TB detection from sputum  (smear positive),98,97,98,NA,NA,NA,18275,Sputum,NA,NA,Sunnyvale,https://cepheid.com,United States,"Sunnyvale, United States",37.3736763,-122.03657532,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB rpoB gene,Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb94,Xpert MTB/RIF,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; US FDA 510k; WHO recommended; Other,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,Yes,Active TB,Other,Independent,TB detection from sputum (smear negative),67,62,72,98,98,99,18962,Sputum,NA,NA,Sunnyvale,https://cepheid.com,United States,"Sunnyvale, United States",37.3736763,-122.03657532,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB rpoB gene,Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb94,Xpert MTB/RIF,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; US FDA 510k; WHO recommended; Other,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,Yes,Active TB,Other,Independent,RIF detection from sputum,96,94,97,98,98,99,8020,Sputum,NA,NA,Sunnyvale,https://cepheid.com,United States,"Sunnyvale, United States",37.3736763,-122.03657532,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB IS1081; MTB IS6110,Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb95,Xpert MTB/RIF Ultra,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,60,Yes,Yes,Active TB,Other,Independent,TB detection from sputum,90,84,94,96,93,97,2654,Sputum,NA,NA,Sunnyvale,https://cepheid.com,United States,"Sunnyvale, United States",37.3736763,-122.03657532,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB IS1081; MTB IS6110,Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb95,Xpert MTB/RIF Ultra,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,60,Yes,Yes,Active TB,Other,Independent,RIF detection from sputum,94.9,88.9,97.9,99.1,97.7,99.8,930,Sputum,NA,NA,Sunnyvale,https://cepheid.com,United States,"Sunnyvale, United States",37.3736763,-122.03657532,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Not applicable,Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb96,Xpert MTB/XDR,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,INH detection from sputum,95.2,92.9,96.8,95.6,90.1,98.1,596,Sputum,464,132,Sunnyvale,https://cepheid.com,United States,"Sunnyvale, United States",37.3736763,-122.03657532,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Not applicable,Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb96,Xpert MTB/XDR,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,FLQ detection from sputum,94.5,90.7,96.9,95.2,92.5,96.9,594,Sputum,226,368,Sunnyvale,https://cepheid.com,United States,"Sunnyvale, United States",37.3736763,-122.03657532,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Not applicable,Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb96,Xpert MTB/XDR,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,AMK detection from sputum,87.7,77.5,93.6,98.5,97,99.2,593,Sputum,65,528,Sunnyvale,https://cepheid.com,United States,"Sunnyvale, United States",37.3736763,-122.03657532,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Not applicable,Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb96,Xpert MTB/XDR,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,KAN detection from sputum,93.7,89,96.4,92.4,89.4,94.6,594,Sputum,195,399,Sunnyvale,https://cepheid.com,United States,"Sunnyvale, United States",37.3736763,-122.03657532,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Not applicable,Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb96,Xpert MTB/XDR,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,CAP detection from sputum,75.4,64,84,99.6,98.6,99.9,595,Sputum,54,541,Sunnyvale,https://cepheid.com,United States,"Sunnyvale, United States",37.3736763,-122.03657532,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Not applicable,Amikacin; Capreomycin; Ethionamide; Fluoroquinolone; Isoniazid; Kanamycin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb96,Xpert MTB/XDR,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; oxyR-ahpC intergenic region; rrs,NA,Automated (excluding sample preparation),Intended for professional use only,90,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,ETH detection from sputum,55,49.5,60.3,93.8,90.3,96.1,597,Sputum,194,403,Sunnyvale,https://cepheid.com,United States,"Sunnyvale, United States",37.3736763,-122.03657532,Low complexity,WHO
Latent,Triage/Screening,Tuberculosis,Antigen,MTB CFP-10; MTB ESAT-6,Not applicable,NA,Whole Blood,NA,a2r69000007lbFE,T-SPOT.TB,Oxford Immunotec Limited,United Kingdom,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,ELISA/EIA; IGRA,Unspecified,A proprietary/new instrument is optional,Lab-based,Colorimetric,Not applicable,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Abingdon,https://oxfordimmunotec.com,United Kingdom,"Abingdon, United Kingdom",51.66964722,-1.27949834,Not applicable,WHO
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,MTB IS6110; MTB pab gene,Not applicable,NA,Bronchoalveolar lavage; Sputum; Other,NALC treated sputum and bronchialalveolar lavages,a2r69000007lbLJ,Abbott RealTime MTB,Abbott Molecular,United States,Region of the Americas,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,Not applicable,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,Yes,Active TB,Systematic review + Meta-analysis,Independent,TB detection from sputum,96.2,90.2,98.6,97.1,93.7,98.7,4858,Sputum,NA,NA,Des Plaines,https://abbottmolecular.com/home.html,United States,"Des Plaines, United States",42.04229736,-87.88932037,Moderate complexity,WHO
Active,Diagnostic/confirmatory test,Drug Resistance,DNA,Not applicable,Isoniazid; Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,NALC treated sputum and bronchialalveolar lavages,a2r69000007lb6C,Abbott RealTime MTB RIF/INH,Abbott Molecular,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,RIF resistance from sputum,94.8,88.3,98.3,100,97,100,216,Sputum,91,125,Des Plaines,https://abbottmolecular.com/home.html,United States,"Des Plaines, United States",42.04229736,-87.88932037,Moderate complexity,WHO
Active,Diagnostic/confirmatory test,Drug Resistance,DNA,Not applicable,Isoniazid; Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,NALC treated sputum and bronchialalveolar lavages,a2r69000007lb6C,Abbott RealTime MTB RIF/INH,Abbott Molecular,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,INH resistance from sputum,88.3,80,94,94.3,88.6,97.7,217,Sputum,90,127,Des Plaines,https://abbottmolecular.com/home.html,United States,"Des Plaines, United States",42.04229736,-87.88932037,Moderate complexity,WHO
Active,Diagnostic/confirmatory test,Drug Resistance,DNA,Not applicable,Isoniazid; Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,NALC treated sputum and bronchialalveolar lavages,a2r69000007lb6C,Abbott RealTime MTB RIF/INH,Abbott Molecular,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,Yes,Active TB,Systematic review + Meta-analysis,Independent,RIF resistance from sputum & culture isolates,94,89,99,100,99,100,1008,Sputum; Sputum Culture,NA,NA,Des Plaines,https://abbottmolecular.com/home.html,United States,"Des Plaines, United States",42.04229736,-87.88932037,Moderate complexity,WHO
Active,Diagnostic/confirmatory test,Drug Resistance,DNA,Not applicable,Isoniazid; Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,NALC treated sputum and bronchialalveolar lavages,a2r69000007lb6C,Abbott RealTime MTB RIF/INH,Abbott Molecular,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,Yes,Active TB,Systematic review + Meta-analysis,Independent,INH resistance from sputum & culture isolates,89,86,92,99,98,100,1013,Sputum; Sputum Culture,NA,NA,Des Plaines,https://abbottmolecular.com/home.html,United States,"Des Plaines, United States",42.04229736,-87.88932037,Moderate complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB IS1081; MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Other,Sputum Sediment,a2r69000007lbEr,BD MAX MDR-TB,"Becton, Dickinson and Company (BD)",United States,Region of the Americas,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,240,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,TB detection,94.5,91.7,96.4,94.9,91.1,97.1,596,Sputum,371,225,Franklin Lakes,https://bd.com,United States,"Franklin Lakes, United States",41.00812912,-74.21038818,Moderate complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB IS1081; MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Other,Sputum Sediment,a2r69000007lbEr,BD MAX MDR-TB,"Becton, Dickinson and Company (BD)",United States,Region of the Americas,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,240,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,RIF resistance from sputum,100,87.1,100,100,98.2,100,232,Sputum,26,206,Franklin Lakes,https://bd.com,United States,"Franklin Lakes, United States",41.00812912,-74.21038818,Moderate complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB IS1081; MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Other,Sputum Sediment,a2r69000007lbEr,BD MAX MDR-TB,"Becton, Dickinson and Company (BD)",United States,Region of the Americas,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,240,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,INH detection from sputum,100,91.8,100,100,98.1,100,242,Sputum,43,199,Franklin Lakes,https://bd.com,United States,"Franklin Lakes, United States",41.00812912,-74.21038818,Moderate complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB IS1081; MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Other,Sputum Sediment,a2r69000007lbEr,BD MAX MDR-TB,"Becton, Dickinson and Company (BD)",United States,Region of the Americas,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,240,Yes,Yes,Active TB,Systematic review + Meta-analysis,Independent,INH detection from sputum,82,63,92,100,98,100,232,Sputum,NA,NA,Franklin Lakes,https://bd.com,United States,"Franklin Lakes, United States",41.00812912,-74.21038818,Moderate complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB IS1081; MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Other,Sputum Sediment,a2r69000007lbEr,BD MAX MDR-TB,"Becton, Dickinson and Company (BD)",United States,Region of the Americas,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,240,Yes,Yes,Active TB,Systematic review + Meta-analysis,Independent,TB detection from sputum,93,89,96,97,96,98,892,Sputum,NA,NA,Franklin Lakes,https://bd.com,United States,"Franklin Lakes, United States",41.00812912,-74.21038818,Moderate complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB IS1081; MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Other,Sputum Sediment,a2r69000007lbEr,BD MAX MDR-TB,"Becton, Dickinson and Company (BD)",United States,Region of the Americas,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,240,Yes,Yes,Active TB,Systematic review + Meta-analysis,Independent,RIF detection from sputum,90,55,100,95,91,97,232,Sputum,NA,NA,Franklin Lakes,https://bd.com,United States,"Franklin Lakes, United States",41.00812912,-74.21038818,Moderate complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Private,Isoniazid; Rifampicin,NA,Bronchoalveolar lavage; Sputum; Urine,NA,a2r69000007lbEs,AccuPower TB&MDR RealTime PCR kit-A,Bioneer Corporation,"Korea, Republic of",Western Pacific Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,Private,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Unknown,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Daejeon,https://bioneer.com,South Korea,"Daejeon, Korea, Republic of",36.34912872,127.38493346999999,Moderate complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Private,Amikacin; Fluoroquinolone; Kanamycin,NA,Bronchoalveolar lavage; Sputum; Sputum Culture,NA,a2r69000007lbF4,AccuPower XDR-TB RealTime PCR kit-A,Bioneer Corporation,"Korea, Republic of",Western Pacific Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,Private,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Unknown,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Daejeon,https://bioneer.com,South Korea,"Daejeon, Korea, Republic of",36.34912872,127.38493346999999,Moderate complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Private,Ethambutol; Streptomycin,NA,Bronchoalveolar lavage; Sputum; Sputum Culture,NA,a2r69000007lbF5,AccuPower XDR-TB RealTime PCR kit-B,Bioneer Corporation,"Korea, Republic of",Western Pacific Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,Private,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Unknown,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Daejeon,https://bioneer.com,South Korea,"Daejeon, Korea, Republic of",36.34912872,127.38493346999999,Moderate complexity,Pipe
Latent,Triage/Screening,Tuberculosis,Antigen,MTB CFP-10; MTB ESAT-6,Not applicable,NA,Other,injection under skin,a2r69000007lbFM,Cy-Tb skin test,Serum Institute of India,India,South-East Asian Region,Regulatory Achieved,WHO recommended,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Host Immune Response,Other,No instrumentation is required,True Point of Care,Colorimetric,Not applicable,Injectable,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Pune,https://seruminstitute.com,India,"Pune, India",18.52890396,73.8743515,Not applicable,WHO
Active,Diagnostic/confirmatory test,Tuberculosis,Antigen,Private,Not applicable,NA,Urine,NA,a2r69000007lbLA,Standard F TB LAM Ag FIA,"SD Biosensor, Inc.","Korea, Republic of",Western Pacific Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Private,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Fluorescence,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Suwon-si,https://sdbiosensor.com,South Korea,"Suwon-si, Korea, Republic of",37.25973511,127.00894928,Low complexity,Pipe
Active,Triage/Screening,Tuberculosis,Antigen,Private,Not applicable,NA,Urine,NA,a2r69000007lbFJ,FLOW TB Urine LAM Assay,Salus Discovery,United States,Region of the Americas,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Private,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Madison,https://salusd.com,United States,"Madison, United States",43.07392502,-89.38524628,Low complexity,Pipe
Latent,Triage/Screening,Tuberculosis,Antigen,Interferon Gamma,Not applicable,NA,Whole Blood,NA,a2r69000006Skdn,Wantai TB-IGRA,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd",China,Western Pacific Region,Regulatory Achieved,China NMPA; WHO recommended,NA,Mycobacterium Tuberculosis,NA,Immunoassay,ELISA/EIA; IGRA,IA Reagent Kit,Standard lab instrumentation is required,Lab-based,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,NA,0,0,Beijing,https://ystwt.cn,China,"Beijing, China",39.9078064,116.39758301,Not applicable,WHO
Active,Triage/Screening,Tuberculosis,Antibody (serological),Private,Not applicable,NA,Plasma; Serum; Whole Blood,NA,a2r69000007lbLH,NOVA Test Tuberculosis IGG/IGM Tri-line Test,"Atlas Link Technology Co., Ltd.",China,Western Pacific Region,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Private,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Private,NA,Manual,Intended for professional use only,15,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,HeBei,https://atlas-link.com,China,"HeBei, China",39.30455017,115.00488281,Not applicable,Pipe
Active,Triage/Screening,Tuberculosis,Antibody (serological),Private,Not applicable,NA,Serum,NA,a2r69000007lbLI,NOVA Test Tuberculosis Antibody Test,"Atlas Link Technology Co., Ltd.",China,Western Pacific Region,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Private,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Private,NA,Manual,Intended for professional use only,15,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,HeBei,https://atlas-link.com,China,"HeBei, China",39.30455017,115.00488281,Not applicable,Pipe
Latent,Triage/Screening,Tuberculosis,Antigen,Private,Not applicable,NA,Other,injection under skin,a2r69000007lbLK,Recombinant mycobacterium tuberculosis fusion protein(EC)n,Anhui Zhifei Longcom Biopharmaceutical Co. Ltd.,China,Western Pacific Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Private,Other,No instrumentation is required,True Point of Care,Colorimetric,Private,Injectable,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Anhui,https://zflongkema.com,China,"Anhui, China",31.82392883,117.23145294,Not applicable,Pipe
Latent,Triage/Screening,Tuberculosis,Antigen,Private,Not applicable,NA,Cerebrospinal fluid (CSF); Other,Pleural fluid; Pericardial fluid; Peritoneal fluid;,a2r69000007lbLL,IRISA-TB,Antrum Biotech,South Africa,African Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Private,Chemiluminescent Immunoassay (CLIA),Standard lab instrumentation is required,Lab-based,Colorimetric,Private,NA,Manual,Intended for professional use only,120,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Cape Town,https://antrumbiotech.co,South Africa,"Cape Town, South Africa",-33.92710876,18.42006111,Not applicable,Pipe
Active,Diagnostic/confirmatory test,Drug Resistance,DNA,Private,Rifampicin,NA,Sputum; Sputum Culture,NA,a2r69000007lb6F,MeltPro MTB/RIF Test Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,CE-IVDD; Other,China CDFA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Private,NAT reagent kit (proprietary platform),Standard lab instrumentation is required,Lab-based,Fluorescence,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Xiamen City,https://zeesandx.com,China,"Xiamen City, China",24.47950935,118.08947754,Moderate complexity,Pipe
Active,Diagnostic/confirmatory test,Drug Resistance,DNA,Private,Amikacin; Capreomycin; Kanamycin,NA,Sputum; Sputum Culture,NA,a2r69000007lb6B,MeltPro MTB/SL Test Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Private,NAT reagent kit (proprietary platform),Standard lab instrumentation is required,Lab-based,Fluorescence,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Xiamen City,https://zeesandx.com,China,"Xiamen City, China",24.47950935,118.08947754,Moderate complexity,Pipe
Active,Diagnostic/confirmatory test,Drug Resistance,DNA,Private,Isoniazid,NA,Sputum; Sputum Culture,NA,a2r69000007lb6H,MeltPro MTB/INH Test Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,CE-IVDD; Other,China CDFA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Private,NAT reagent kit (proprietary platform),Standard lab instrumentation is required,Lab-based,Fluorescence,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Xiamen City,https://zeesandx.com,China,"Xiamen City, China",24.47950935,118.08947754,Moderate complexity,Pipe
Active,Diagnostic/confirmatory test,Drug Resistance,DNA,Private,Streptomycin,NA,Sputum; Sputum Culture,NA,a2r69000007lb6G,MeltPro MTB/STR Test Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,CE-IVDD; Other,China CDFA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Private,NAT reagent kit (proprietary platform),Standard lab instrumentation is required,Lab-based,Fluorescence,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Xiamen City,https://zeesandx.com,China,"Xiamen City, China",24.47950935,118.08947754,Moderate complexity,Pipe
Active,Diagnostic/confirmatory test,Drug Resistance,DNA,Private,Fluoroquinolone,NA,Sputum; Sputum Culture,NA,a2r69000007lb6J,MeltPro MTB/FQ Test Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,CE-IVDD; Other,China CDFA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Private,NAT reagent kit (proprietary platform),Standard lab instrumentation is required,Lab-based,Fluorescence,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Xiamen City,https://zeesandx.com,China,"Xiamen City, China",24.47950935,118.08947754,Moderate complexity,Pipe
Active,Diagnostic/confirmatory test,Drug Resistance,DNA,Private,Ethambutol,NA,Sputum; Sputum Culture,NA,a2r69000007lb6I,MeltPro MTB/EMB Test Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,CE-IVDD; Other,China CDFA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Private,NAT reagent kit (proprietary platform),Standard lab instrumentation is required,Lab-based,Fluorescence,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Xiamen City,https://zeesandx.com,China,"Xiamen City, China",24.47950935,118.08947754,Moderate complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,Private,Not applicable,NA,Sputum; Sputum Culture,NA,a2r69000007lbFP,MeltPro Mycobacteria Identification Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,Private,NAT reagent kit (proprietary platform),Standard lab instrumentation is required,Lab-based,Fluorescence,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Xiamen City,https://zeesandx.com,China,"Xiamen City, China",24.47950935,118.08947754,Moderate complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,Private,Not applicable,NA,Bronchoalveolar lavage; Sputum,NA,a2r69000007lbFO,MeltPro TB Assay,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,Other,China CDFA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Private,NAT reagent kit (proprietary platform),Standard lab instrumentation is required,Lab-based,Fluorescence,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Xiamen City,https://zeesandx.com,China,"Xiamen City, China",24.47950935,118.08947754,Moderate complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,Private,Not applicable,NA,Sputum; Sputum Culture,NA,a2r69000007lbFQ,MeltPro Mycobacterium Tuberculosis McSpoligotyping Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Private,NAT reagent kit (proprietary platform),Standard lab instrumentation is required,Lab-based,Fluorescence,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Xiamen City,https://zeesandx.com,China,"Xiamen City, China",24.47950935,118.08947754,Moderate complexity,Pipe
Latent,Triage/Screening,Tuberculosis,RNA,Private,Not applicable,NA,Purified RNA,NA,a2r69000007lb8t,T-Track TB part 2 - T-Track TB Quant PCR,Mikrogen GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,Private,NAT reagent kit (open source),A proprietary/new instrument is optional,Lab-based,Fluorescence,Private,NA,Manual,Intended for professional use only,180,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Bavaria,https://mikrogen.de,Germany,"Bavaria, Germany",48.94681168,11.41901207,Not applicable,Pipe
Active,"Monitoring (treatment, immune status, patient)",Host Response,RNA,Private,Not applicable,NA,Whole Blood,NA,a2r69000007lb8w,TB22 signature in-house assay,Research Center Borstel,Germany,European Region,Early Stage Development (partial prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,Private,Unspecified,Unknown,Lab-based,Fluorescence,Private,NA,Unknown,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Borstel,https://fz-borstel.de/index.php/en,Germany,"Borstel, Germany",52.66984177,8.97046089,Not applicable,Pipe
Active,"Monitoring (treatment, immune status, patient)",Host Response,RNA,Private,Not applicable,NA,Finger prick blood,NA,a2r69000007lb8z,RISK 6 host response assay,QuantuMDx Group Limited,United Kingdom,European Region,Early Stage Development (partial prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,Private,Unspecified,Unknown,Lab-based,Fluorescence,Private,NA,Unknown,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Newcastle upon Tyne,https://quantumdx.com,United Kingdom,"Newcastle upon Tyne, United Kingdom",54.97790527,-1.6086086,Not applicable,Pipe
Latent,Triage/Screening,Tuberculosis,Antigen,Private,Not applicable,NA,Whole Blood,Blood stimulation tubes,a2r69000007lbEy,T-Track TB part 1 - T-Track TB Stimulation,Mikrogen GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Private,Other,A proprietary/new instrument is optional,Lab-based,Fluorescence,Private,Stimulation/incubation,Manual,Intended for professional use only,1440,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Bavaria,https://mikrogen.de,Germany,"Bavaria, Germany",48.94681168,11.41901207,Not applicable,Pipe
Active,Triage/Screening,Tuberculosis,DNA,Private,Not applicable,NA,Saliva; Urine,NA,a2r69000007lbL8,RidTB,GenEndeavor llc,United States,Region of the Americas,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,Private,Rapid diagnostic test (strip or cassette),Standard lab instrumentation is required,near Point of Care,Colorimetric,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Pleasanton,https://Genendeavor.com,United States,"Pleasanton, United States",37.65843582,-121.8769989,Low complexity,Pipe
Active,Triage/Screening,Tuberculosis,Antigen,Private,Not applicable,NA,Other,Heamolysate,a2r69000007lb8p,Erythra-TB-KIT,Erythra Inc.,China,Western Pacific Region,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Private,Rapid diagnostic test (strip or cassette),No instrumentation is required,near Point of Care,Colorimetric,Private,NA,Manual,Intended for professional use only,5,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Yangzhou,http://www.genenexus.com/,China,"Yangzhou, China",32.39442062,119.41364288,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,MTB gyrB Gene; Other,Not applicable,NA,Sputum,NA,a2r69000007lb8j,Loopamp MTBC Detection Kit,"Eiken Chemical Co., Ltd.",Japan,Western Pacific Region,Regulatory Achieved,CE-IVDR; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Isothermal LAMP,NAT reagent kit (open source),Standard lab instrumentation is required,near Point of Care,Fluorescence,Not applicable,NA,Manual,Intended for professional use only,40,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Otawara,https://eiken.co.jp,Japan,"Otawara, Japan",36.8709259,140.01560974,Not applicable,WHO
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,Private,Not applicable,NA,Sputum; Sputum Culture; Other,EPTB specimen,a2r69000007lbEz,Mylab PathoDetect MTB Detection kit,Mylab Discovery Solutions Pvt. Ltd.,India,South-East Asian Region,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Private,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Unknown,Intended for professional use only,80,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Pune,https://mylabglobal.com,India,"Pune, India",18.52890396,73.8743515,Moderate complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Private,Isoniazid; Rifampicin,NA,Sputum; Sputum Culture; Other,EPTB specimen,a2r69000007lbF0,Mylab PathoDetect MTB RIF and INH resistance detection kit,Mylab Discovery Solutions Pvt. Ltd.,India,South-East Asian Region,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Private,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Unknown,Intended for professional use only,80,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Pune,https://mylabglobal.com,India,"Pune, India",18.52890396,73.8743515,Moderate complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Private,Bedaquiline,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb68,Truenat MTB-BDQ,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,"Verna Industrial Estate, Verna,",https://molbiodiagnostics.com,India,"Verna Industrial Estate, Verna,, India",15.34916973,73.93138885,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Private,Fluoroquinolone,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb67,Truenat MTB-FQ,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,"Verna Industrial Estate, Verna,",https://molbiodiagnostics.com,India,"Verna Industrial Estate, Verna,, India",15.34916973,73.93138885,Low complexity,Pipe
Active,"Monitoring (treatment, immune status, patient)",Tuberculosis,Antigen,Private,Not applicable,NA,Whole Blood,NA,a2r69000007lbL5,T cell activation marker (TAM-TB) assay,Beckman Coulter Inc.,United States,Region of the Americas,Early Stage Development (partial prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Private,Other,A proprietary/new instrument is required,Lab-based,Fluorescence,Private,Flow cytometry,Unknown,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Pasadena,https://beckmancoulter.com,United States,"Pasadena, United States",34.14955139,-118.14144897,Not applicable,Pipe
Active,"Triage/Screening; Monitoring (treatment, immune status, patient)",Tuberculosis,Antigen,Private,Not applicable,NA,Sputum,NA,a2r69000007lbL9,PATHFAST-LAM,LSI Medience Corporation,Japan,Western Pacific Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Private,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Minato-ku,https://medience.co.jp,Japan,"Minato-ku, Japan",35.65807343,139.75140381,Low complexity,Pipe
Active,Triage/Screening,Tuberculosis,Antigen,Private,Not applicable,NA,Urine,NA,a2r69000007lbLE,gLAMexpress,Mologic Ltd.,United Kingdom,European Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Private,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Thurleigh,https://mologic.co.uk,United Kingdom,"Thurleigh, United Kingdom",52.21430206,-0.45711488,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Private,Isoniazid; Rifampicin,NA,Sputum,NA,a2r69000007lbEn,TruArray MDR-TB,"Akonni Biosystems, Inc.",United States,Region of the Americas,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Private,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,Private,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Frederick,https://akonni.com,United States,"Frederick, United States",39.41418076,-77.41093445,High complexity,Pipe
Active,Diagnostic/confirmatory test,Drug Resistance,DNA,Not applicable,Rifampicin,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb6D,Truenat MTB-RIF Dx,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,RIF detection from sputum,84.2,62.4,94.5,95.2,90.8,97.5,0,Sputum,0,0,"Verna Industrial Estate, Verna,",https://molbiodiagnostics.com,India,"Verna Industrial Estate, Verna,, India",15.34916973,73.93138885,Low complexity,WHO
Active,Diagnostic/confirmatory test,Drug Resistance,DNA,Not applicable,Rifampicin,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb6D,Truenat MTB-RIF Dx,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,Yes,Active TB,Other,Independent,RIF detection from sputum,84,62,95,95,91,98,186,Sputum,19,167,"Verna Industrial Estate, Verna,",https://molbiodiagnostics.com,India,"Verna Industrial Estate, Verna,, India",15.34916973,73.93138885,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,MTB nrdB gene,Not applicable,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb8k,Truenat MTB,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,TB detection from pulmonary and EPTB specimen,91.1,0,0,100,0,0,226,Sputum,191,35,"Verna Industrial Estate, Verna,",https://molbiodiagnostics.com,India,"Verna Industrial Estate, Verna,, India",15.34916973,73.93138885,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,MTB nrdB gene,Not applicable,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb8k,Truenat MTB,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,Yes,Active TB,Other,Independent,TB detection from sputum,73,68,78,98,97,99,1336,Sputum,258,1078,"Verna Industrial Estate, Verna,",https://molbiodiagnostics.com,India,"Verna Industrial Estate, Verna,, India",15.34916973,73.93138885,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,MTB nrdB gene,Not applicable,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb8k,Truenat MTB,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,Yes,Active TB,Other,Independent,TB detection from sputum (smear positive),91,86,94,NA,NA,NA,174,Sputum,174,0,"Verna Industrial Estate, Verna,",https://molbiodiagnostics.com,India,"Verna Industrial Estate, Verna,, India",15.34916973,73.93138885,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,MTB nrdB gene,Not applicable,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb8k,Truenat MTB,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,Yes,Active TB,Other,Independent,TB detection  from sputum (smear negative),37,27,48,98,97,99,1162,Sputum,84,1078,"Verna Industrial Estate, Verna,",https://molbiodiagnostics.com,India,"Verna Industrial Estate, Verna,, India",15.34916973,73.93138885,Low complexity,WHO
Active,Diagnostic/confirmatory test,Drug Resistance,DNA,Private,Isoniazid,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb6E,Truenat MTB-INH,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,INH detection from sputum,100,0,0,96.15,0,0,50,Sputum,0,0,"Verna Industrial Estate, Verna,",https://molbiodiagnostics.com,India,"Verna Industrial Estate, Verna,, India",15.34916973,73.93138885,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,MTB IS6110; MTB nrdz gene,Not applicable,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb8l,Truenat MTB Plus,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,TB detection from sputum,79.8,74.5,84.3,96.5,95.2,97.4,1654,Sputum,0,0,"Verna Industrial Estate, Verna,",https://molbiodiagnostics.com,India,"Verna Industrial Estate, Verna,, India",15.34916973,73.93138885,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,MTB IS6110; MTB nrdz gene,Not applicable,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb8l,Truenat MTB Plus,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,Yes,Active TB,Other,Independent,TB detection from sputum,80,75,84,96,95,97,1336,Sputum,258,1078,"Verna Industrial Estate, Verna,",https://molbiodiagnostics.com,India,"Verna Industrial Estate, Verna,, India",15.34916973,73.93138885,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,MTB IS6110; MTB nrdz gene,Not applicable,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb8l,Truenat MTB Plus,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,Yes,Active TB,Other,Independent,TB detection from sputum (smear positive),96,92,98,NA,NA,NA,174,Sputum,174,0,"Verna Industrial Estate, Verna,",https://molbiodiagnostics.com,India,"Verna Industrial Estate, Verna,, India",15.34916973,73.93138885,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,MTB IS6110; MTB nrdz gene,Not applicable,NA,Purified DNA,Sputum or EPTB specimen,a2r69000007lb8l,Truenat MTB Plus,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Not applicable,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,Yes,Active TB,Other,Independent,TB detection from sputum (smear negative),46,36,57,97,95,97,1162,Sputum,84,1078,"Verna Industrial Estate, Verna,",https://molbiodiagnostics.com,India,"Verna Industrial Estate, Verna,, India",15.34916973,73.93138885,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Private,Isoniazid; Rifampicin,NA,Bronchoalveolar lavage; Sputum; Urine; Other,Cavitary Fluid; Biopsies/Tissue Bronchial Aspirate (BA); Gastric Aspirates,a2r69000007lbF9,MDR/MTB ELITe MGB Kit for InGenius platform,ELITechGroup,France,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD,NA,Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Private,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,Private,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Puteaux,https://elitechgroup.com,France,"Puteaux, France",48.88328552,2.23760176,Moderate complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,Private,Not applicable,NA,Bronchoalveolar lavage; Sputum; Urine; Other,Cavitary Fluid; Biopsies/Tissue Bronchial Aspirate (BA); Gastric Aspirates,a2r69000007lbFA,MTB EXTRA ELITe MGB Kit for InGenius platform,ELITechGroup,France,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD,NA,Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Private,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,Private,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Puteaux,https://elitechgroup.com,France,"Puteaux, France",48.88328552,2.23760176,Moderate complexity,Pipe
Active,Diagnostic/confirmatory test,Drug Resistance,DNA,Not applicable,Pyrazinamide,NA,Sputum; Other,Culture,a2r69000007lb69,Genoscholar PZA-TB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,pncA,NA,Manual,Intended for professional use only,1440,Yes,Yes,Active TB,Other,Independent,PZA detection from sputum culture,81.2,75.4,85.8,97.8,96.5,98.6,964,Sputum Culture,NA,NA,"3-9-3, Honjo-Nishi, Kita-ku,",https://nipro.co.jp,Japan,"3-9-3, Honjo-Nishi, Kita-ku,, Japan",35.70628533,139.80304086,High complexity,WHO
Active,Diagnostic/confirmatory test,Drug Resistance,DNA,Not applicable,Pyrazinamide,NA,Sputum; Other,Culture,a2r69000007lb69,Genoscholar PZA-TB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,pncA,NA,Manual,Intended for professional use only,1440,Yes,Yes,Active TB,Other,Independent,PZA detection from sputum culture,96.4,93.3,98.4,100,99.4,100,NA,Sputum Culture,NA,NA,"3-9-3, Honjo-Nishi, Kita-ku,",https://nipro.co.jp,Japan,"3-9-3, Honjo-Nishi, Kita-ku,, Japan",35.70628533,139.80304086,High complexity,WHO
Active,Diagnostic/confirmatory test,Drug Resistance,DNA,Not applicable,Pyrazinamide,NA,Sputum; Other,Culture,a2r69000007lb69,Genoscholar PZA-TB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,pncA,NA,Manual,Intended for professional use only,1440,Yes,Yes,Active TB,Other,Independent,PZA detection from sputum culture,95.7,93.5,97.2,98.6,97.4,99.2,NA,Sputum Culture,NA,NA,"3-9-3, Honjo-Nishi, Kita-ku,",https://nipro.co.jp,Japan,"3-9-3, Honjo-Nishi, Kita-ku,, Japan",35.70628533,139.80304086,High complexity,WHO
Active,Diagnostic/confirmatory test,Drug Resistance,DNA,Private,Fluoroquinolone; Kanamycin,NA,Sputum; Other,Culture,a2r69000007lbll,Genoscholar FQ+KM-TB II,Nipro Corporation,Japan,Western Pacific Region,Research Use Only (RUO),Unknown,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Private,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,Private,NA,Manual,Intended for professional use only,1440,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,"3-9-3, Honjo-Nishi, Kita-ku,",https://nipro.co.jp,Japan,"3-9-3, Honjo-Nishi, Kita-ku,, Japan",35.70628533,139.80304086,Moderate complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Other,Culture,a2r69000007lbFD,Genoscholar NTM+MDRTB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,inhA promoter; katG; rpoB,NA,Manual,Intended for professional use only,1440,Yes,Yes,Active TB,Other,Independent,RIF detection from sputum,NA,75,100,NA,96.5,100,NA,Sputum,NA,NA,"3-9-3, Honjo-Nishi, Kita-ku,",https://nipro.co.jp,Japan,"3-9-3, Honjo-Nishi, Kita-ku,, Japan",35.70628533,139.80304086,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Other,Culture,a2r69000007lbFD,Genoscholar NTM+MDRTB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,inhA promoter; katG; rpoB,NA,Manual,Intended for professional use only,1440,Yes,Yes,Active TB,Other,Independent,INH detection from sputum,NA,50,94.9,NA,96.5,97.8,NA,Sputum,NA,NA,"3-9-3, Honjo-Nishi, Kita-ku,",https://nipro.co.jp,Japan,"3-9-3, Honjo-Nishi, Kita-ku,, Japan",35.70628533,139.80304086,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Other,Culture,a2r69000007lbFD,Genoscholar NTM+MDRTB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,inhA promoter; katG; rpoB,NA,Manual,Intended for professional use only,1440,Yes,Yes,Active TB,Other,Independent,RIF detection from culture isolates,NA,92.8,98.9,NA,97.3,98.2,NA,Sputum Culture,NA,NA,"3-9-3, Honjo-Nishi, Kita-ku,",https://nipro.co.jp,Japan,"3-9-3, Honjo-Nishi, Kita-ku,, Japan",35.70628533,139.80304086,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB IS6110,Isoniazid; Rifampicin,NA,Sputum; Other,Culture,a2r69000007lbFD,Genoscholar NTM+MDRTB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,inhA promoter; katG; rpoB,NA,Manual,Intended for professional use only,1440,Yes,Yes,Active TB,Other,Independent,INH detection from culture isolates,NA,61.6,91.6,NA,99.4,100,NA,Sputum Culture,NA,NA,"3-9-3, Honjo-Nishi, Kita-ku,",https://nipro.co.jp,Japan,"3-9-3, Honjo-Nishi, Kita-ku,, Japan",35.70628533,139.80304086,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Not applicable,Isoniazid; Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb6A,cobas MTB-RIF/INH,Roche Diagnostics International AG,Switzerland,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Manual,Intended for professional use only,NA,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,RIF detection from sputum,96.7,91.7,99.1,97.9,95.8,99.2,NA,Sputum,NA,NA,Rotkreuz,https://molecular.roche.com,Switzerland,"Rotkreuz, Switzerland",47.13299942,8.46700001,Moderate complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Not applicable,Isoniazid; Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb6A,cobas MTB-RIF/INH,Roche Diagnostics International AG,Switzerland,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Manual,Intended for professional use only,NA,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,INH detection from sputum,97.4,93.5,99.3,99.3,97.6,99.9,NA,Sputum,NA,NA,Rotkreuz,https://molecular.roche.com,Switzerland,"Rotkreuz, Switzerland",47.13299942,8.46700001,Moderate complexity,WHO
Latent,Triage/Screening,Tuberculosis,Antigen,Private,Not applicable,NA,Plasma,Li-Heprin,a2r69000007lb93,ichroma IGRA-TB 25,Boditech Med Inc.,"Korea, Republic of",Western Pacific Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Chuncheon-s,https://boditech.co.kr/en,South Korea,"Chuncheon-s, Korea, Republic of",37.86963272,127.73867798,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Private,Isoniazid; Rifampicin,NA,Sputum,NA,a2r69000007lbFK,STANDARD M MDR-TB,"SD Biosensor, Inc.","Korea, Republic of",Western Pacific Region,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Automated (excluding sample preparation),Intended for professional use only,30,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Suwon-si,https://sdbiosensor.com,South Korea,"Suwon-si, Korea, Republic of",37.25973511,127.00894928,Low complexity,Pipe
Latent,Triage/Screening,Tuberculosis,Antigen,Private,Not applicable,NA,Plasma,sensitized whole blood in TB-Feron Tubes,a2r69000007lbLC,STANDARD F TB-Feron FIA,"SD Biosensor, Inc.","Korea, Republic of",Western Pacific Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Private,Rapid diagnostic test (strip or cassette),A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Manual,Intended for professional use only,15,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Suwon-si,https://sdbiosensor.com,South Korea,"Suwon-si, Korea, Republic of",37.25973511,127.00894928,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,Private,Not applicable,NA,Unknown,NA,a2r69000007lbLB,STANDARD M MTB/NTM,"SD Biosensor, Inc.","Korea, Republic of",Western Pacific Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Suwon-si,https://sdbiosensor.com,South Korea,"Suwon-si, Korea, Republic of",37.25973511,127.00894928,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Private,Rifampicin,NA,Sputum,NA,a2r69000007lbF2,Gendrive MTB/RIF ID,Epistem Limited,United Kingdom,European Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Manchester,https://epistem.co.uk,United Kingdom,"Manchester, United Kingdom",53.47867584,-2.24383903,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Private,Amikacin; Capreomycin; Fluoroquinolone; Kanamycin,NA,Unknown,NA,a2r69000007lb8x,STANDARD M XDR-TB,"SD Biosensor, Inc.","Korea, Republic of",Western Pacific Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Suwon-si,https://sdbiosensor.com,South Korea,"Suwon-si, Korea, Republic of",37.25973511,127.00894928,Low complexity,Pipe
Latent,Triage/Screening,Tuberculosis,Antigen,Private,Not applicable,NA,Whole Blood,NA,a2r69000007lbL6,VIDAS TB-IGRA,bioMérieux,France,European Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Private,Other,A proprietary/new instrument is required,Lab-based,Fluorescence,Private,Reagent strip,Automated (excluding sample preparation),Intended for professional use only,1020,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Marcy l'Etoile,https://biomerieux-diagnostics.com,France,"Marcy l'Etoile, France",45.78102875,4.70581245,Not applicable,Pipe
Latent,"Monitoring (treatment, immune status, patient)",Host Response,RNA,Private,Not applicable,NA,Whole Blood,NA,a2r69000007lbL7,ISIT-TB,bioMérieux,France,European Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,Lab-based,Fluorescence,Private,NA,Unknown,Intended for professional use only,60,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Marcy l'Etoile,https://biomerieux-diagnostics.com,France,"Marcy l'Etoile, France",45.78102875,4.70581245,Not applicable,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis,Antigen,Private,Not applicable,NA,Plasma; Serum,NA,a2r69000007lbFC,NanoDetect-TB test,NanoPin Technologies,United States,Region of the Americas,Regulatory Status Unknown,None,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Private,Laboratory-developed test (LDT),Standard lab instrumentation is required,Lab-based,Other,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,NEW ORLEANS,https://nanopintech.com,United States,"NEW ORLEANS, United States",29.95176315,-90.07461548,Not applicable,Pipe
Active,Triage/Screening,Tuberculosis,DNA,Private,Not applicable,NA,Other,tongue,a2r69000007lbAY,LumiraDx MTB qSTAR Test,LumiraDx Limited,United Kingdom,European Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,2023,Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Electrochemical,Private,chip based,Automated (excluding sample preparation),Intended for professional use only,15,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,London,https://lumiradx.com/us-en/what-we-do/diagnostics/fast-lab-solutions,United Kingdom,"London, United Kingdom",51.50682449,-0.12611847,Low complexity,Pipe
Active,"Monitoring (treatment, immune status, patient)",Host Response,RNA,Private,Not applicable,NA,Whole Blood,NA,a2r69000007lb97,Xpert MTB Host Response assay,Cepheid,United States,Region of the Americas,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Sunnyvale,https://cepheid.com,United States,"Sunnyvale, United States",37.3736763,-122.03657532,Low complexity,Pipe
Active,Triage/Screening,Tuberculosis,Antigen,Private,Not applicable,NA,Whole Blood,NA,a2r69000007lbLG,Simoa SR-X,Quanterix,United States,Region of the Americas,Early Stage Development (partial prototype),Unknown,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Private,Unspecified,A proprietary/new instrument is required,Lab-based,Fluorescence,Private,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Lexington,https://quanterix.com,United States,"Lexington, United States",38.0463562,-84.49702454,Not applicable,Pipe
Latent,Triage/Screening,Tuberculosis,Antigen,Interferon Gamma,Not applicable,NA,Whole Blood,Blood stimulation tubes,a2r69000007lbFF,QuantiFERON-TB Gold Plus (QFT-Plus),QIAGEN GmbH,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; China NMPA; US FDA PMA; WHO recommended,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,ELISA/EIA; IGRA,Chemiluminescent Immunoassay (CLIA),Standard lab instrumentation is required,Lab-based,Colorimetric,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Germantown,https://www.qiagen.com,United States,"Germantown, United States",35.08452988,-89.78726959,Not applicable,WHO
Active,Triage/Screening,Tuberculosis,Antibody (serological),Private,Not applicable,NA,Whole Blood,NA,a2r69000007lb8u,MARTI point-of-care TB diagnostic test,MARTI TB Diagnostics (Pty) Ltd,South Africa,African Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Electrochemical,Private,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Pretoria,https://martidiagnostic.com,South Africa,"Pretoria, South Africa",-25.74601936,28.18712044,Not applicable,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,Private,Not applicable,NA,Unknown,NA,a2r69000007lb90,Q-POC - TB Assay,QuantuMDx Group Limited,United Kingdom,European Region,Early Stage Development (partial prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Newcastle upon Tyne,https://quantumdx.com,United Kingdom,"Newcastle upon Tyne, United Kingdom",54.97790527,-1.6086086,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone,SLID resistance,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8m,GenoType MTBDRsl VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,embB; gyrA; rrs,NA,Manual,Intended for professional use only,300,Yes,Yes,Active TB,Other,Independent,SLID detection from  culture (indirect),76.5,63.3,86,99.1,97.3,99.7,1921,Sputum Culture,NA,NA,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone,SLID resistance,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8m,GenoType MTBDRsl VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,embB; gyrA; rrs,NA,Manual,Intended for professional use only,300,Yes,Yes,Active TB,Other,Independent,SLID detection from sputum (direct),87,38.1,98.6,99.5,93.6,100,1639,Sputum,NA,NA,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone,NA,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8m,GenoType MTBDRsl VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,embB; gyrA; rrs,NA,Manual,Intended for professional use only,300,Yes,Yes,Active TB,Other,Independent,FLQ detection from culture (indirect),85.6,79.2,90.4,98.5,95.7,99.5,2233,Sputum Culture,NA,NA,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone,NA,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8m,GenoType MTBDRsl VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,embB; gyrA; rrs,NA,Manual,Intended for professional use only,300,Yes,Yes,Active TB,Other,Independent,FLQ detection from sputum (direct),86.2,74.6,93,98.6,96.9,99.4,1771,Sputum,NA,NA,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone,XDR-TB resistance,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8m,GenoType MTBDRsl VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,embB; gyrA; rrs,NA,Manual,Intended for professional use only,300,Yes,Yes,Active TB,Other,Independent,XDR-TB detection from culture (indirect),70.9,42.9,88.8,98.8,96.1,99.6,880,Sputum Culture,NA,NA,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone,XDR-TB resistance,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8m,GenoType MTBDRsl VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,embB; gyrA; rrs,NA,Manual,Intended for professional use only,300,Yes,Yes,Active TB,Other,Independent,XDR-TB detection from sputum (direct),69.4,38.8,89,99.4,95,99.3,1420,Sputum,NA,NA,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone; Kanamycin,NA,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8n,GenoType MTBDRsl VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,eis promoter; gyrA; gyrB; rrs,NA,Manual,Intended for professional use only,300,Yes,No,Active TB,Other,Independent,TB Detection,0,0,0,0,0,0,0,Sputum,0,0,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone; Kanamycin,NA,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8n,GenoType MTBDRsl VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,eis promoter; gyrA; gyrB; rrs,NA,Manual,Intended for professional use only,300,Yes,No,Active TB,Other,Independent,Fluoroquinolone resistance,0,0,0,0,0,0,0,Sputum,0,0,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone; Kanamycin,SLID resistance,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8n,GenoType MTBDRsl VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,eis promoter; gyrA; gyrB; rrs,NA,Manual,Intended for professional use only,300,Yes,No,Active TB,Other,Independent,SLID resistance,0,0,0,0,0,0,0,Sputum,0,0,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone; Kanamycin,NA,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8n,GenoType MTBDRsl VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,eis promoter; gyrA; gyrB; rrs,NA,Manual,Intended for professional use only,300,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,TB detection from sputum,98.8,0,0,89.6,0,0,331,Sputum,259,72,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone; Kanamycin,NA,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8n,GenoType MTBDRsl VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,eis promoter; gyrA; gyrB; rrs,NA,Manual,Intended for professional use only,300,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,FLQ detection from sputum,93.1,0,0,100,0,0,251,Sputum,54,197,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone; Kanamycin,NA,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8n,GenoType MTBDRsl VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,eis promoter; gyrA; gyrB; rrs,NA,Manual,Intended for professional use only,300,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,AMK detection from sputum,94.7,0,0,98.1,0,0,251,Sputum,40,211,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone; Kanamycin,NA,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8n,GenoType MTBDRsl VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,eis promoter; gyrA; gyrB; rrs,NA,Manual,Intended for professional use only,300,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,CAP detection from sputum,90,0,0,98.1,0,0,251,Sputum,40,211,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB 23S rRNA,Ethambutol; Fluoroquinolone; Kanamycin,NA,Sputum; Sputum Culture,Sputum Culture isolates,a2r69000007lb8n,GenoType MTBDRsl VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,eis promoter; gyrA; gyrB; rrs,NA,Manual,Intended for professional use only,300,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,KAN detection from sputum,94.8,0,0,96.6,0,0,251,Sputum,79,172,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Private,Amikacin; Ethambutol; Fluoroquinolone; Linezolid,NA,Sputum; Sputum Culture,liquid Sputum Culture from Mgit,a2r69000007lb8q,LiquidArray MTB-XDR VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Private,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,Private,NA,Automated (excluding sample preparation),Intended for professional use only,180,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,Moderate complexity,Pipe
Latent,Triage/Screening,Tuberculosis,Antigen,Private,Not applicable,NA,Whole Blood,NA,a2r69000007lbFG,LIAISON QuantiFERON-TB Gold Plus assay,QIAGEN GmbH,United States,Region of the Americas,Regulatory Achieved,CE-IVDD; US FDA PMA,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Private,Chemiluminescent Immunoassay (CLIA),A proprietary/new instrument is required,Lab-based,Colorimetric,Private,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Germantown,https://www.qiagen.com,United States,"Germantown, United States",35.08452988,-89.78726959,Not applicable,Pipe
Latent,Triage/Screening,Tuberculosis,Antigen,Private,Not applicable,NA,Whole Blood,NA,a2r69000007lbLF,QIAReach QuantiFERON-TB,QIAGEN GmbH,United States,Region of the Americas,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Automated (excluding sample preparation),Intended for professional use only,1440,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Germantown,https://www.qiagen.com,United States,"Germantown, United States",35.08452988,-89.78726959,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,MTB 16S rRNA; Other,Not applicable,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lbFI,cobas MTB,Roche Diagnostics International AG,Switzerland,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,TB detection from sputum,98.9,96.9,99.7,98.2,96.1,99.3,NA,Sputum,NA,NA,Rotkreuz,https://molecular.roche.com,Switzerland,"Rotkreuz, Switzerland",47.13299942,8.46700001,Moderate complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,MTB 16S rRNA; Other,Not applicable,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lbFI,cobas MTB,Roche Diagnostics International AG,Switzerland,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,Not applicable,NA,Manual,Intended for professional use only,NA,Yes,No,Active TB,Instructions for Use (IFU),Company-Sponsored,TB detection from sputum,98.9,96.9,99.7,98.2,96.1,99.3,0,Sputum,0,0,Rotkreuz,https://molecular.roche.com,Switzerland,"Rotkreuz, Switzerland",47.13299942,8.46700001,Moderate complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB 23S rRNA,Isoniazid; Rifampicin,NA,Sputum; Sputum Culture; Other,bronchial material; Aspirates,a2r69000007lbEv,GenoType MTBDRplus VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,inhA promoter; katG; rpoB,NA,Manual,Intended for professional use only,300,Yes,Yes,Active TB,Other,Independent,RIF detection from sputum,95.8,92.6,97.6,98.4,96.9,99.2,NA,Sputum,NA,NA,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB 23S rRNA,Isoniazid; Rifampicin,NA,Sputum; Sputum Culture; Other,bronchial material; Aspirates,a2r69000007lbEv,GenoType MTBDRplus VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,inhA promoter; katG; rpoB,NA,Manual,Intended for professional use only,300,Yes,Yes,Active TB,Other,Independent,INH detection from sputum,94.5,91.4,96.5,99.3,92.6,100,NA,Sputum,NA,NA,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB 23S rRNA,Isoniazid; Rifampicin,NA,Sputum; Sputum Culture; Other,bronchial material; Aspirates,a2r69000007lbEv,GenoType MTBDRplus VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,inhA promoter; katG; rpoB,NA,Manual,Intended for professional use only,300,Yes,Yes,Active TB,Other,Independent,RIF detection from culture isolates,91.3,86,95,98,94.3,98.7,NA,Sputum Culture,NA,NA,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB 23S rRNA,Isoniazid; Rifampicin,NA,Sputum; Sputum Culture; Other,bronchial material; Aspirates,a2r69000007lbEv,GenoType MTBDRplus VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Hybridization,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Colorimetric,inhA promoter; katG; rpoB,NA,Manual,Intended for professional use only,300,Yes,Yes,Active TB,Other,Independent,INH detection from culture isolates,89.4,84.3,93.3,98.9,96,99.9,NA,Sputum Culture,NA,NA,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,High complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Private,Not applicable,NA,Sputum; Sputum Culture,liquid Sputum Culture from Mgit,a2r69000007lbF1,FluoroType Mycobacteria VER 1.0 PCR Kit,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Private,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,Private,NA,Automated (excluding sample preparation),Intended for professional use only,180,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,Moderate complexity,Pipe
Latent,Triage/Screening,Tuberculosis,Antigen,MTB CFP-10; MTB ESAT-6,Not applicable,NA,Other,injection under skin,a2r69000007lbF3,Diaskintest,Generium,Russian Federation,European Region,Regulatory Achieved,WHO recommended,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Host Immune Response,Other,No instrumentation is required,True Point of Care,Colorimetric,Not applicable,Injectable,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Moscow,https://generium.ru/en,Russian Federation,"Moscow, Russian Federation",55.75654221,37.61492157,Not applicable,WHO
Active,Triage/Screening,Tuberculosis,Antigen,Private,Not applicable,NA,Finger prick blood,NA,a2r69000007lbEw,TB Triage multiplex LFA,Leiden Unversity Medical Center,Netherlands,European Region,Early Stage Development (partial prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Private,Rapid diagnostic test (strip or cassette),No instrumentation is required,near Point of Care,Colorimetric,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Leiden,https://lumc.nl,Netherlands,"Leiden, Netherlands",52.16108704,4.49015284,Low complexity,Pipe
Latent,Triage/Screening,Tuberculosis,Antigen,Private,Not applicable,NA,Whole Blood,Blood stimulation tubes,a2r69000007lbEx,LIOFeron TB/LTBI IGRA; HUMAN IFN-g ELISA KIT,LIONEX Diagnostics & Therapeutics GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Private,Chemiluminescent Immunoassay (CLIA),Standard lab instrumentation is required,Lab-based,Colorimetric,Private,NA,Manual,Intended for professional use only,1440,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Braunschweig,https://lionex.de,Germany,"Braunschweig, Germany",52.26415253,10.52642345,Not applicable,Pipe
Latent,Triage/Screening,Tuberculosis,Antigen,Private,Not applicable,NA,Whole Blood,heprin,a2r69000007lb8v,AdvanSure TB-IGRA ELISA,LG Chem Life Sciences Company,United States,Region of the Americas,Research Use Only (RUO),None,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Private,Chemiluminescent Immunoassay (CLIA),Standard lab instrumentation is required,Lab-based,Colorimetric,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Cambridge,https://innovation.lgchem.com,United States,"Cambridge, United States",42.36524963,-71.10501862,Not applicable,Pipe
Active,"Monitoring (treatment, immune status, patient)",Tuberculosis,RNA,Private,Not applicable,NA,Sputum,NA,a2r69000007lb8s,TB-MBLA,LifeArc,United Kingdom,European Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,2023,Molecular,Private,NAT reagent kit (open source),Standard lab instrumentation is required,Lab-based,Fluorescence,Private,NA,Manual,Intended for professional use only,300,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,London,https://lifearc.org,United Kingdom,"London, United Kingdom",51.50682449,-0.12611847,Not applicable,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Private,Isoniazid; Rifampicin,NA,Sputum,NA,a2r69000007lbF7,Genechip MDR kit,CapitalBio Technology,China,Western Pacific Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,Lab-based,Fluorescence,Private,microarray chip based,Unknown,Intended for professional use only,NA,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Beijing,https://capitalbiotech.com/en/index.html,China,"Beijing, China",39.9078064,116.39758301,Not applicable,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Private,Ethambutol; Fluoroquinolone; Isoniazid; Rifampicin; Streptomycin,NA,Sputum,NA,a2r69000007lbEp,Mycobacterium Tuberculosis and Drug Resistance Gene Rapid NAT Test Kit,"Bao Ruiyuan Biotech(Beijing) Co.,ltd.",China,Western Pacific Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Automated (excluding sample preparation),Intended for professional use only,60,Yes,NA,NA,NA,Company-Sponsored,NA,0,0,0,0,0,0,0,NA,0,0,Beijing,https://abiores.com,China,"Beijing, China",39.9078064,116.39758301,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,MTB IS6110,NA,NA,Sputum,NA,a2r69000009kS4Z,FluoroType MTB VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,NA,NA,Automated (excluding sample preparation),Intended for professional use only,180,Yes,Yes,Active TB,Systematic review + Meta-analysis,Independent,TB detection from sputum,92.1,87.6,93.3,98.9,64,99.9,2660,Sputum,NA,NA,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,Moderate complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB rpoB gene,Isoniazid; Rifampicin,NA,Sputum,NA,a2r69000009kS4e,FluoroType MTBDR VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,180,Yes,Yes,Active TB,Systematic review + Meta-analysis,Independent,TB detection from sputum,NA,91,96,100,97,100,782,Sputum,NA,NA,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,Moderate complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB rpoB gene,Isoniazid; Rifampicin,NA,Sputum,NA,a2r69000009kS4e,FluoroType MTBDR VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,180,Yes,Yes,Active TB,Systematic review + Meta-analysis,Independent,RIF detection from sputum & culture isolates,NA,97,99,100,85,100,231,Sputum; Sputum Culture,NA,NA,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,Moderate complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB rpoB gene,Isoniazid; Rifampicin,NA,Sputum,NA,a2r69000009kS4e,FluoroType MTBDR VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,180,Yes,Yes,Active TB,Systematic review + Meta-analysis,Independent,INH detection from sputum & culture isolates,NA,70,92,100,84,100,207,Sputum; Sputum Culture,NA,NA,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,Moderate complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB IS1081; MTB IS6110,Rifampicin,NA,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,a2r69000007lb95,Xpert MTB/RIF Ultra,Cepheid,United States,Region of the Americas,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,qPCR,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,60,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Sunnyvale,https://cepheid.com,United States,"Sunnyvale, United States",37.3736763,-122.03657532,Low complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,MTB rpoB gene,Isoniazid; Rifampicin,NA,Sputum; Sputum Culture,liquid Sputum Culture from Mgit,a2r69000007lbEu,FluoroType MTBDR VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Brazil ANVISA; CE-IVDD; WHO recommended,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,inhA promoter; katG; rpoB,NA,Automated (excluding sample preparation),Intended for professional use only,180,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,Moderate complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis,Antigen,Private,Not applicable,NA,Urine,NA,a2rVj0000000N33,Ultrasensitive lateral-flow assay platform for TB LAM test,Auragent Bioscience LLC,United States,Region of the Americas,Early Stage Development (partial prototype),NA,NA,Mycobacterium Tuberculosis,Unknown,Immunoassay,Private,Rapid diagnostic test (strip or cassette),A proprietary/new instrument is required,True Point of Care,Fluorescence,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Overland,https://auragentbio.com,United States,"Overland, United States",38.69413376,-90.36322021,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,Private,NA,NA,Other,Tongue swab,a2r6900000859rG,Pluslife MTB Card,"Guangzhou Pluslife Biotech Co., ltd.",China,Western Pacific Region,Late Stage Development (fully functional prototype),NA,NA,Mycobacterium Tuberculosis,Unspecified Market Entry,Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Fully automated (including sample preparation),Intended for professional use only,30,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Guangzhou,https://pluslife.com,China,"Guangzhou, China",23.12907982,113.26435852,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,Private,Not applicable,NA,Other,Tongue swab,a2r6900000859rL,Co-Dx PCR Mycobacterium Tuberculosis Test Kit,Co-Diagnostics Inc.,United States,Region of the Americas,Late Stage Development (fully functional prototype),NA,NA,Mycobacterium Tuberculosis Complex Species,Unspecified Market Entry,Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Automated (excluding sample preparation),Intended for professional use only,30,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Salt Lake City,https://Co-dx.com,United States,"Salt Lake City, United States",40.75847626,-111.88814545,Low complexity,Pipe
Active,Triage/Screening,Tuberculosis,DNA,Private,Not applicable,NA,Other,Tongue swab,a2r6900000859tM,LEGIO TB,Gemina Laboratories,Canada,Region of the Americas,Early Stage Development (partial prototype),NA,NA,Mycobacterium Tuberculosis Complex Species,2024,Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,NA,Private,NA,NA,Intended for professional use only,30,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Burnaby,NA,Canada,"Burnaby, Canada",49.24377441,-122.98169708,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,MTB IS6110,NA,NA,Sputum,NA,a2r69000009kS45,FluoroType MTB VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,CE-IVDD; WHO recommended,WHO recommended,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,qPCR,NAT reagent kit (proprietary platform),A proprietary/new instrument is required,Lab-based,Fluorescence,NA,NA,Automated (excluding sample preparation),Intended for professional use only,180,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Nehren,https://hain-lifescience.de/en/,Germany,"Nehren, Germany",48.43112564,9.06929016,Moderate complexity,WHO
Active,Diagnostic/confirmatory test,Tuberculosis,Antigen,Private,Not applicable,NA,Urine,NA,a2r69000009kSiA,High sensitive LAM,Abbott Rapid Diagnostics,Germany,European Region,Late Stage Development (fully functional prototype),NA,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Unspecified Market Entry,Immunoassay,Private,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Unspecified,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Groß-Rohrheim,https://globalpointofcare.abbott/en/index.html,Germany,"Groß-Rohrheim, Germany",49.71524811,8.47291756,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis,Antigen,Private,Not applicable,NA,Urine,NA,a2r69000009kSec,TB LAM urine LFA,Biopromic AB,Sweden,European Region,Late Stage Development (fully functional prototype),NA,NA,Mycobacterium Tuberculosis,Unspecified Market Entry,Immunoassay,Private,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Solna,https://biopromic.com,Sweden,"Solna, Sweden",59.36136627,18.00136948,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis,Antigen,Private,Not applicable,NA,Urine,NA,a2r69000009kSeX,Fujifilm SILVAMP TB LAM,FUJIFILM Corporation,Japan,Western Pacific Region,Validation,NA,NA,Mycobacterium Tuberculosis,Unspecified Market Entry,Immunoassay,Private,Rapid diagnostic test (strip or cassette),No instrumentation is required,True Point of Care,Colorimetric,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Kanagawa,https://fujifilm.com,Japan,"Kanagawa, Japan",35.4175415,139.33943176,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Private,Isoniazid; Rifampicin,NA,Sputum,NA,a2r69000009kSdZ,mfloDx MDR-TB kit,EMPE Diagnostics,Sweden,European Region,Regulatory Status Unknown,None,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Molecular,Private,Rapid diagnostic test (strip or cassette),Standard lab instrumentation is required,near Point of Care,Colorimetric,Private,NA,Manual,Intended for professional use only,180,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Solna,https://empediagnostics.com,Sweden,"Solna, Sweden",59.36136627,18.00136948,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,Private,Not applicable,NA,Purified DNA,Sputum or EPTB specimen,a2r69000009kShb,Truenat Ultima,Molbio Diagnostics Pvt. Ltd.,India,South-East Asian Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis,Unknown,Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,chip based,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Verna Industrial Estate, Verna,",https://molbiodiagnostics.com,India,"Verna Industrial Estate, Verna,, India",15.34916973,73.93138885,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis,Antigen,Private,Not applicable,NA,Urine,NA,a2r69000009kShW,AIMLAM,"Leide Biosciences Co. , Ltd.",China,Western Pacific Region,Regulatory Status Unknown,NA,NA,Mycobacterium Tuberculosis,Already on the market (commercialized),Immunoassay,Private,Rapid diagnostic test (strip or cassette),A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Manual,Intended for professional use only,NA,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Guang zhou,https://leidebio.com,China,"Guang zhou, China",23.12907982,113.26435852,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis + Drug Resistance,DNA,Private,Rifampicin,NA,Sputum,NA,a2r69000009kSiF,MultNAT MTB/RIF,Ustar Biotechnologies (Hangzhou) Ltd.,China,Western Pacific Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Unspecified Market Entry,Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Automated (excluding sample preparation),Intended for professional use only,NA,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Hangzhou,https://en.bioustar.com,China,"Hangzhou, China",30.24592018,120.21079254,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,Private,Not applicable,NA,Other,Tongue swab,a2r69000009kSiB,PortNAT MTB,Ustar Biotechnologies (Hangzhou) Ltd.,China,Western Pacific Region,Late Stage Development (fully functional prototype),None,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Unspecified Market Entry,Molecular,Private,Cartridge-based processing,No instrumentation is required,True Point of Care,Unspecified,Private,NA,Manual,Intended for professional use only,30,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Hangzhou,https://en.bioustar.com,China,"Hangzhou, China",30.24592018,120.21079254,Low complexity,Pipe
Active,Diagnostic/confirmatory test,Tuberculosis,DNA,Private,Not applicable,NA,Bronchoalveolar lavage; Sputum; Urine,NA,a2r69000009kSi0,EasyNAT MTC,Ustar Biotechnologies (Hangzhou) Ltd.,China,Western Pacific Region,Regulatory Achieved,Brazil ANVISA; CE-IVDR,NA,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,Already on the market (commercialized),Molecular,Private,Cartridge-based processing,A proprietary/new instrument is required,near Point of Care,Fluorescence,Private,NA,Automated (excluding sample preparation),Intended for professional use only,65,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Hangzhou,https://en.bioustar.com,China,"Hangzhou, China",30.24592018,120.21079254,Low complexity,Pipe
